Risk prediction is advancing due to discoveries that highlight microvascular changes and their effect on disease progression.
All articles by K. Patricia Bouweraerts, MA
Lower vessel density and higher nonperfusion of deep capillary plexus on OCT-A is associated with diabetic retinopathy complications by 1 year.
The intravitreal injection improves acuity and reduces retinal fluid in a 12-week therapy regimen for patients with diabetic macular edema, researchers report.
Using a dexamethasone implant to treat diabetic macular edema, visual acuity improved by 4.3 ETDRS letters, compared with 1.4 after laser therapy.
Analysis of VIVID/VISTA and PANORAMA shows early treatment is better for diabetic macular edema and nonproliferative retinopathy.